Hailun Wang

Instructor

20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Hailun Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
tax Gene Products Medicine & Life Sciences
Epithelial-Mesenchymal Transition Medicine & Life Sciences
Hexosamines Medicine & Life Sciences
Biosynthetic Pathways Medicine & Life Sciences
Glycosylation Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Nude Mice Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations

Phillips, R. M., Lam, C., Wang, H. & Tran, P. T., Jan 1 2019, Advances in Cancer Research. Academic Press Inc., (Advances in Cancer Research).

Research output: Chapter in Book/Report/Conference proceedingChapter

Glycosylation
Epithelial-Mesenchymal Transition
Hexosamines
Biosynthetic Pathways
Neoplasms
Hexosamines
Lung
Biosynthetic Pathways
Transaminases
Glutamine

O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis

Taparra, K., Wang, H., Malek, R., Lafargue, A., Barbhuiya, M. A., Wang, X., Simons, B. W., Ballew, M., Nugent, K., Groves, J., Williams, R. D., Shiraishi, T., Verdone, J., Yildirir, G., Henry, R., Zhang, B., Wong, J., Wang, K-H., Nelkin, B. D., Pienta, K. & 3 others, Felsher, D., Zachara, N. E. & Tran, P. T., Nov 1 2018, In : The Journal of clinical investigation. 128, 11, p. 4924-4937 14 p.

Research output: Contribution to journalArticle

Hexosamines
Biosynthetic Pathways
Carcinogenesis
Lung
Glycosylation

Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer

Yochum, Z. A., Cades, J., Wang, H., Chatterjee, S., Simons, B. W., O’Brien, J. P., Khetarpal, S. K., Lemtiri-Chlieh, G., Myers, K. V., Huang, E. H. B., Rudin, C. M., Tran, P. T. & Burns, T. F., Jan 1 2018, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Transcription Factors
Harmine
Apoptosis

A first-in-class twist1 inhibitor with activity in oncogene-driven lung cancer

Yochum, Z. A., Cades, J., Mazzacurati, L., Neumann, N. M., Khetarpal, S. K., Chatterjee, S., Wang, H., Attar, M. A., Huang, E. H. B., Chatley, S. N., Nugent, K., Somasundaram, A., Engh, J. A., Ewald, A., Cho, Y. J., Rudin, C. M., Tran, P. T. & Burns, T. F., Dec 1 2017, In : Molecular Cancer Research. 15, 12, p. 1764-1776 13 p.

Research output: Contribution to journalArticle

Harmine
Oncogenes
Lung Neoplasms
Non-Small Cell Lung Carcinoma
Epithelial-Mesenchymal Transition